- Home
- GYRE vs CTOS Comparison
GYRE vs CTOS Comparison
Compare GYRE & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- CTOS
- Stock Information
- Founded
- GYRE 2002
- CTOS 1988
- Country
- GYRE United States
- CTOS United States
- Employees
- GYRE N/A
- CTOS N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- CTOS Diversified Commercial Services
- Sector
- GYRE Health Care
- CTOS Consumer Discretionary
- Exchange
- GYRE Nasdaq
- CTOS Nasdaq
- Market Cap
- GYRE 997.3M
- CTOS 1.1B
- IPO Year
- GYRE N/A
- CTOS N/A
- Fundamental
- Price
- GYRE $11.54
- CTOS $4.62
- Analyst Decision
- GYRE
- CTOS Buy
- Analyst Count
- GYRE 0
- CTOS 5
- Target Price
- GYRE N/A
- CTOS $6.90
- AVG Volume (30 Days)
- GYRE 53.5K
- CTOS 684.0K
- Earning Date
- GYRE 03-25-2025
- CTOS 03-04-2025
- Dividend Yield
- GYRE N/A
- CTOS N/A
- EPS Growth
- GYRE N/A
- CTOS N/A
- EPS
- GYRE N/A
- CTOS N/A
- Revenue
- GYRE $105,033,000.00
- CTOS $1,803,294,000.00
- Revenue This Year
- GYRE $25.32
- CTOS N/A
- Revenue Next Year
- GYRE $12.95
- CTOS $1.99
- P/E Ratio
- GYRE N/A
- CTOS N/A
- Revenue Growth
- GYRE N/A
- CTOS N/A
- 52 Week Low
- GYRE $8.26
- CTOS $3.03
- 52 Week High
- GYRE $26.37
- CTOS $6.48
- Technical
- Relative Strength Index (RSI)
- GYRE 47.99
- CTOS 38.36
- Support Level
- GYRE $12.09
- CTOS $5.01
- Resistance Level
- GYRE $12.80
- CTOS $5.28
- Average True Range (ATR)
- GYRE 0.56
- CTOS 0.23
- MACD
- GYRE -0.00
- CTOS -0.06
- Stochastic Oscillator
- GYRE 16.39
- CTOS 2.96
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.